341 related articles for article (PubMed ID: 22841836)
1. The emerging role of epigenetic modifiers linking cellular metabolism and gene activity in cardiac progenitor cells.
Boonsanay V; Kim J; Braun T; Zhou Y
Trends Cardiovasc Med; 2012 Apr; 22(3):77-81. PubMed ID: 22841836
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of cardiovascular differentiation.
Ohtani K; Dimmeler S
Cardiovasc Res; 2011 Jun; 90(3):404-12. PubMed ID: 21372004
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells.
Zhou Y; Kim J; Yuan X; Braun T
Circ Res; 2011 Oct; 109(9):1067-81. PubMed ID: 21998298
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
6. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
Geiman TM; Robertson KD
J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
[TBL] [Abstract][Full Text] [Related]
7. Control of cardiac growth by histone acetylation/deacetylation.
Backs J; Olson EN
Circ Res; 2006 Jan; 98(1):15-24. PubMed ID: 16397154
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of genomic imprinting and clinical implications for cancer.
Uribe-Lewis S; Woodfine K; Stojic L; Murrell A
Expert Rev Mol Med; 2011 Jan; 13():e2. PubMed ID: 21262060
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
10. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and cardiovascular development.
Chang CP; Bruneau BG
Annu Rev Physiol; 2012; 74():41-68. PubMed ID: 22035349
[TBL] [Abstract][Full Text] [Related]
12. Stress, epigenetic control of gene expression and memory formation.
Trollope AF; Gutièrrez-Mecinas M; Mifsud KR; Collins A; Saunderson EA; Reul JM
Exp Neurol; 2012 Jan; 233(1):3-11. PubMed ID: 21466804
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular epigenetics: from DNA methylation to microRNAs.
Udali S; Guarini P; Moruzzi S; Choi SW; Friso S
Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780
[TBL] [Abstract][Full Text] [Related]
14. Establishing epigenetic domains via chromatin-bound histone modifiers.
Erdel F; Müller-Ott K; Rippe K
Ann N Y Acad Sci; 2013 Dec; 1305():29-43. PubMed ID: 24033539
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
D'Alessio AC; Szyf M
Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
[TBL] [Abstract][Full Text] [Related]
16. Every methyl counts--epigenetic calculus.
Scharf AN; Imhof A
FEBS Lett; 2011 Jul; 585(13):2001-7. PubMed ID: 21108946
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
18. [Epigenetic mechanism of cardiac differentiation of stem cells].
Zhu H; Liu Y; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
Herceg Z; Paliwal A
Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
[TBL] [Abstract][Full Text] [Related]
20. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.
Franci G; Miceli M; Altucci L
Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
